SonoScape Medical Corp. (SHE:300633)

Market Cap	11.14B -10.7%
Revenue (ttm)	2.07B +1.2%
Net Income	66.92M -72.4%
EPS	0.15 -72.2%
Shares Out	429.82M
PE Ratio	167.20
Forward PE	41.80
Dividend	0.10 (0.39%)
Ex-Dividend Date	May 29, 2025

Volume	3,139,276
Average Volume	2,880,601
Open	25.42
Previous Close	25.25
Day's Range	25.32 - 26.23
52-Week Range	25.14 - 37.73
Beta	-0.39
RSI	39.27
Earnings Date	Apr 17, 2026

About SonoScape Medical

SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. The company offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, light sources, gastroenterology and pulmonology products, endoscopic ultrasound, duodenoscopes, and peripheral equipment; minimally invasive surge...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 3,122
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300633

Financial Performance

In 2024, SonoScape Medical's revenue was 2.01 billion, a decrease of -5.02% compared to the previous year's 2.12 billion. Earnings were 142.40 million, a decrease of -68.67%.